Seeking Alpha: Salesforce, Inc. (CRM) Presents At 44th Annual J.P. Morgan Healthcare Conference Transcript Salesforce, Inc.
(CRM) Presents At 44th Annual J.P. Morgan Healthcare Conference Transcript Will one of America’s most innovative companies be able to disrupt healthcare? Earlier this week, Reuters broke the news of Salesforce.com’s plans to enter the healthcare industry. The cloud-based CRM ...
salesforce healthcare crm, Business Wire: ZS acquires Torrent Consulting to fuel Salesforce’s healthcare, life sciences AI solutions Torrent Consulting’s Salesforce capabilities will augment ZS’s healthcare expertise and AI innovation to deliver measurable value for patients, providers and life sciences organizations EVANSTON, Ill. ZS acquires Torrent Consulting to fuel Salesforce’s healthcare, life sciences AI solutions Insider Monkey on MSN: Salesforce (CRM) Traded Lower Due to Market Fears Over AI Disruption Seeking Alpha: Haleon Selects Salesforce Agentforce Life Sciences Cloud for Customer Engagement to Improve Engagement with Pharmacies and Healthcare Professionals with AI LONDON & SAN FRANCISCO--(BUSINESS WIRE)-- Haleon plc (LSE/NYSE:HLN), a leading global consumer company that specialises in everyday health and Salesforce (NYSE:CRM), the world’s #1 AI CRM, today ... Haleon Selects Salesforce Agentforce Life Sciences Cloud for Customer Engagement to Improve Engagement with Pharmacies and Healthcare Professionals with AI Salesforce, Inc. (NYSE:CRM) is one of the 11 Best Large-Cap Tech Stocks to Invest In. On March 5, Salesforce, Inc.
salesforce healthcare crm, (NYSE:CRM) announced six new Agentforce Health agents with pre-wired integrations to ... Nasdaq: Veeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy? Veeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy? Salesforce Inc (NYSE: CRM) shares moved higher Wednesday after the company secured a major win with Novartis selecting its Agentforce Life Sciences platform for global customer engagement, while BTIG ...
Salesforce (CRM) came out with quarterly earnings of $3.81 per share, beating the Zacks Consensus Estimate of $3.03 per share. This compares to earnings of $2.78 per share a year ago. These figures ...
